SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,605,938 | +5.7% | 7,557 | -3.3% | 0.00% | +50.0% |
| Q2 2023 | $1,518,693 | -73.5% | 7,811 | -72.4% | 0.00% | -77.8% |
| Q1 2023 | $5,733,343 | +30.7% | 28,317 | -17.1% | 0.01% | +28.6% |
| Q4 2022 | $4,387,717 | -35.2% | 34,143 | -31.0% | 0.01% | -41.7% |
| Q3 2022 | $6,773,000 | -41.3% | 49,502 | -24.1% | 0.01% | -33.3% |
| Q2 2022 | $11,533,000 | +23.5% | 65,179 | +0.5% | 0.02% | +38.5% |
| Q1 2022 | $9,341,000 | -30.6% | 64,845 | -25.5% | 0.01% | -27.8% |
| Q4 2021 | $13,452,000 | -6.8% | 87,014 | +2.3% | 0.02% | -10.0% |
| Q3 2021 | $14,437,000 | +13.2% | 85,023 | +5.2% | 0.02% | +11.1% |
| Q2 2021 | $12,756,000 | +28.0% | 80,796 | +12.6% | 0.02% | +20.0% |
| Q1 2021 | $9,967,000 | +235.4% | 71,779 | +323.1% | 0.02% | +150.0% |
| Q4 2020 | $2,972,000 | – | 16,967 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |